Physician profile
Christopher Lecroy
NPI 1821204983
$35,181.41
in general payments reported to CMS, 2019-2025
35 companies · $930 in 2025
The $930 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $4,920 · 2020: $2,438 · 2021: $14K · 2022: $7,860 · 2023: $2,613 · 2024: $2,399 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,942.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $15,333.08 | 2020-2023 | Treo Abdominal Stent-Graft System |
| Endologix LLC | $5,176.94 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $3,030.80 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic, INC. | $2,172.14 | 2021-2025 | Hawkone, Venaseal, Abre |
| Medtronic Vascular, INC. | $1,586.02 | 2019-2020 | |
| Silk Road Medical, INC. | $1,229.49 | 2020-2022 | |
| Angiodynamics, INC. | $1,136.26 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Penumbra, INC. | $895.43 | 2021-2025 | Penumbra System, Indigo System, Ruby Coil |
| Musculoskeletal Transplant Foundation INC. | $834.06 | 2021 | |
| Veryan Medical Incorporated | $645.62 | 2020-2023 | Biomimics 3d Vascular Stent System |
| Philips North America LLC | $441.22 | 2021-2023 | |
| Boston Scientific Corporation | $420.31 | 2019-2024 | Varithena Administration Pack, Peripheral Rotalink Plus, Rotapro |
| Cardiovascular Systems INC. | $381.73 | 2019-2023 | Diamondback Peripheral |
| Bard Peripheral Vascular, INC. | $263.76 | 2021-2025 | Rotarexs 6 F X 135 Cm |
| Reflow Medical INC | $222.04 | 2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $212.57 | 2023-2025 | Diamondback Peripheral, Esprit, Omnilink Elite |
| Pfizer INC. | $174.02 | 2019-2024 | |
| Getinge USA Sales, LLC | $172.28 | 2021-2022 | |
| Cook Medical LLC | $129.50 | 2023 | Cook |
| Janssen Pharmaceuticals, INC | $118.80 | 2019-2024 | Xarelto |
| Mozarc Medical US LLC | $107.60 | 2023 | Chameleon, Palindrome |
| Cardinal Health 200 LLC | $86.12 | 2019-2020 | |
| Kerecis Limited | $50.36 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Allergan, INC. | $48.77 | 2019 | |
| Lemaitre Vascular, INC. | $43.58 | 2022-2023 | Flexcel Carotid Shunt, Hydro Lemaitre Valvulotome |
| Convatec INC. | $41.11 | 2021-2025 | |
| Mimedx Group, INC. | $38.13 | 2024 | |
| Kci USA, INC. | $36.82 | 2019-2023 | Prevena |
| Stability Biologics, LLC | $34.42 | 2022 | |
| Venclose INC. | $31.13 | 2020 | |
| Heraeus Medical, LLC. | $26.46 | 2024 | |
| Organogenesis INC. | $25.36 | 2021 | |
| Biocomposites INC | $23.60 | 2025 | Stimulan |
| Advanced Oxygen Therapy INC. | $11.88 | 2025 | Topical Oxygen Chamber For Extremities |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$52,944.99 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lecroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.